Iterum Therapeutics plc Quarterly Depreciation in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Iterum Therapeutics plc quarterly/annual Depreciation history and growth rate from Q1 2018 to Q1 2024.
  • Iterum Therapeutics plc Depreciation for the quarter ending March 31, 2024 was $7K, unchanged year-over-year.
  • Iterum Therapeutics plc annual Depreciation for 2023 was $31K, a 63.1% decline from 2022.
  • Iterum Therapeutics plc annual Depreciation for 2022 was $84K, a 78.5% decline from 2021.
  • Iterum Therapeutics plc annual Depreciation for 2021 was $391K, a 143% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $7K -$22K -75.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $29K -$6K -17.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $35K -$4K -10.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $39K +$4K +11.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $35K +$4K +12.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $31K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.